Cover Image
市場調查報告書

感染疾病診斷用迅速·POC檢驗 - 開發中產品分析

Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Review, 2015

出版商 GlobalData 商品編碼 344265
出版日期 內容資訊 英文 213 Pages
訂單完成後即時交付
價格
Back to Top
感染疾病診斷用迅速·POC檢驗 - 開發中產品分析 Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Review, 2015
出版日期: 2015年10月01日 內容資訊: 英文 213 Pages
簡介

本報告提供感染疾病診斷用迅速·POC檢驗的開發中產品調查分析,提供您主要開發中產品,主要企業,各開發階段的開發中產品,主要的臨床實驗資料,最近的趨勢等相關的系統性資訊。

第1章 目錄

第2章 簡介

  • 感染疾病診斷用迅速·POC檢驗概要

第3章 開發中的產品

  • 感染疾病診斷用迅速·POC檢驗 - 開發中產品:各開發階段
  • 感染疾病診斷用迅速·POC檢驗 - 開發中產品:各地區
  • 感染疾病診斷用迅速·POC檢驗 - 開發中產品:各法規途徑
  • 感染疾病診斷用迅速·POC檢驗 - 開發中產品:各核准時期 (預定)

第4章 感染疾病診斷用迅速·POC檢驗:正在開發的開發中產品 (各企業)

  • 感染疾病診斷用迅速·POC檢驗企業 - 開發中產品:各開發階段
  • 感染疾病診斷用迅速·POC檢驗 - 開發中產品:各開發階段

第5章 感染疾病診斷用迅速·POC檢驗企業與產品概要

  • A&B Professional di Barsali Brunella
  • Akers Biosciences, Inc.
  • Analyticon Biotechnologies AG
  • Aseptika Ltd
  • Atomo Diagnostics Pty Limited
  • Autoimmune Technologies, LLC
  • BACTERIOSCAN LTD
  • Biocartis SA
  • BioFire Diagnostics, Inc.
  • Biotech Consortium India Limited
  • Calypte Biomedical Corporation
  • Canon U.S.A., Inc.
  • Cepheid
  • Coris BioConcept
  • Denka Seiken Co., Ltd.
  • Diagnostics for the Real World (Europe) Ltd.
  • DIESSE Diagnostica Senese S.p.A.
  • First Light Biosciences, Inc.
  • Foundation for Innovative New Diagnostics
  • Genalyte, Inc.
  • GeneFluidics Inc.
  • Great Basin Corporation
  • Hema Diagnostic Systems, LLC
  • Immunexpress Pty Ltd
  • ImmunoScience, Inc.
  • InBios International, Inc.
  • Infectious Disease Research Institute
  • Innova Biotechnology Co., Ltd.
  • Insilixa, Inc.
  • Institut de Recherche pour le Developpement 等

第6章 感染疾病診斷用迅速·POC檢驗:最近的趨勢

第7章 附錄

圖表

目錄
Product Code: GDME0084EPD

GlobalData's Medical Devices sector report, "Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Review, 2015" provides an overview of Infectious Diagnostics Rapid & Point of Care Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Infectious Diagnostics Rapid & Point of Care Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Infectious Diagnostics Rapid & Point of Care Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Infectious Diagnostics Rapid & Point of Care Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Infectious Diagnostics Rapid & Point of Care Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Infectious Diagnostics Rapid & Point of Care Tests Overview

3. Products under Development

  • 3.1. Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Stage of Development
  • 3.2. Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Segment
  • 3.3. Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Territory
  • 3.4. Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Regulatory Path
  • 3.5. Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Estimated Approval Date

4. Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products under Development by Companies

  • 4.1. Infectious Diagnostics Rapid & Point of Care Tests Companies - Pipeline Products by Stage of Development
  • 4.2. Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Stage of Development

5. Infectious Diagnostics Rapid & Point of Care Tests Companies and Product Overview

  • 5.1. A&B Professional di Barsali Brunella Company Overview
    • 5.1.1. A&B Professional di Barsali Brunella Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Akers Biosciences, Inc. Company Overview
    • 5.2.1. Akers Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Analyticon Biotechnologies AG Company Overview
    • 5.3.1. Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Aseptika Ltd Company Overview
    • 5.4.1. Aseptika Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Atomo Diagnostics Pty Limited Company Overview
    • 5.5.1. Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Autoimmune Technologies, LLC Company Overview
    • 5.6.1. Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. BACTERIOSCAN LTD. Company Overview
    • 5.7.1. BACTERIOSCAN LTD. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Biocartis SA Company Overview
    • 5.8.1. Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. BioFire Diagnostics, Inc. Company Overview
    • 5.9.1. BioFire Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Biotech Consortium India Limited Company Overview
    • 5.10.1. Biotech Consortium India Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Calypte Biomedical Corporation Company Overview
    • 5.11.1. Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Canon U.S.A., Inc. Company Overview
    • 5.12.1. Canon U.S.A., Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Cepheid Company Overview
    • 5.13.1. Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Coris BioConcept Company Overview
    • 5.14.1. Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Denka Seiken Co., Ltd. Company Overview
    • 5.15.1. Denka Seiken Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Diagnostics for the Real World (Europe) Ltd. Company Overview
    • 5.16.1. Diagnostics for the Real World (Europe) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. DIESSE Diagnostica Senese S.p.A. Company Overview
    • 5.17.1. DIESSE Diagnostica Senese S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. First Light Biosciences, Inc. Company Overview
    • 5.18.1. First Light Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Foundation for Innovative New Diagnostics Company Overview
    • 5.19.1. Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Genalyte, Inc. Company Overview
    • 5.20.1. Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. GeneFluidics Inc. Company Overview
    • 5.21.1. GeneFluidics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Great Basin Corporation Company Overview
    • 5.22.1. Great Basin Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Hema Diagnostic Systems, LLC Company Overview
    • 5.23.1. Hema Diagnostic Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Immunexpress Pty Ltd Company Overview
    • 5.24.1. Immunexpress Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. ImmunoScience, Inc. Company Overview
    • 5.25.1. ImmunoScience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. InBios International, Inc. Company Overview
    • 5.26.1. InBios International, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Infectious Disease Research Institute Company Overview
    • 5.27.1. Infectious Disease Research Institute Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Innova Biotechnology Co., Ltd. Company Overview
    • 5.28.1. Innova Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Insilixa, Inc. Company Overview
    • 5.29.1. Insilixa, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Institut de Recherche pour le Developpement Company Overview
    • 5.30.1. Institut de Recherche pour le Developpement Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. Institut Pasteur Company Overview
    • 5.31.1. Institut Pasteur Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Integrated DNA Technologies, Inc. Company Overview
    • 5.32.1. Integrated DNA Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. James Cook University Company Overview
    • 5.33.1. James Cook University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. Labsystems Diagnostics Oy Company Overview
    • 5.34.1. Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. Leiden University Company Overview
    • 5.35.1. Leiden University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. Life Technologies Corporation Company Overview
    • 5.36.1. Life Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. Lucigen Corporation Company Overview
    • 5.37.1. Lucigen Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. Meru University of Science & Technology Company Overview
    • 5.38.1. Meru University of Science & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. Micronics, Inc. (of Sony Group) Company Overview
    • 5.39.1. Micronics, Inc. (of Sony Group) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. NexGen Arrays Company Overview
    • 5.40.1. NexGen Arrays Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. NOWDiagnostics Company Overview
    • 5.41.1. NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. OptiCul Diagnostics Ltd. Company Overview
    • 5.42.1. OptiCul Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. PrimerDesign Limited Company Overview
    • 5.43.1. PrimerDesign Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. Protein Advances Inc. Company Overview
    • 5.44.1. Protein Advances Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45. Quidel Corporation Company Overview
    • 5.45.1. Quidel Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46. Quotient Limited Company Overview
    • 5.46.1. Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47. Randox Laboratories Limited Company Overview
    • 5.47.1. Randox Laboratories Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48. Rockefeller University Company Overview
    • 5.48.1. Rockefeller University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49. Sedia Biosciences Corporation Company Overview
    • 5.49.1. Sedia Biosciences Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50. Sight Diagnostics Ltd. Company Overview
    • 5.50.1. Sight Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.51. Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • 5.51.1. Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.52. Standard Diagnostics, Inc. Company Overview
    • 5.52.1. Standard Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.53. The Johns Hopkins University Company Overview
    • 5.53.1. The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.54. U.S. Army Medical Research Institute of Infectious Diseases Company Overview
    • 5.54.1. U.S. Army Medical Research Institute of Infectious Diseases Pipeline Products & Ongoing Clinical Trials Overview
  • 5.55. University of California, Berkeley Company Overview
    • 5.55.1. University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview
  • 5.56. University of California, Irvine Company Overview
    • 5.56.1. University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview
  • 5.57. University of Edinburgh Company Overview
    • 5.57.1. University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview
  • 5.58. University of Nevada, Reno Company Overview
    • 5.58.1. University of Nevada, Reno Pipeline Products & Ongoing Clinical Trials Overview
  • 5.59. University of Oxford Company Overview
    • 5.59.1. University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
  • 5.60. University of Virginia Company Overview
    • 5.60.1. University of Virginia Pipeline Products & Ongoing Clinical Trials Overview
  • 5.61. Vircell S.L Company Overview
    • 5.61.1. Vircell S.L Pipeline Products & Ongoing Clinical Trials Overview
  • 5.62. Wholehealth Products, Inc. Company Overview
    • 5.62.1. Wholehealth Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.63. Yale University Company Overview
    • 5.63.1. Yale University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.64. Yeda Research and Development Company Ltd. Company Overview
    • 5.64.1. Yeda Research and Development Company Ltd. Pipeline Products & Ongoing Clinical Trials Overview

6. Infectious Diagnostics Rapid & Point of Care Tests- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Stage of Development
  • Table 2: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Segment
  • Table 3: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Territory
  • Table 4: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Regulatory Path
  • Table 5: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Estimated Approval Date
  • Table 6: Infectious Diagnostics Rapid & Point of Care Tests Companies - Pipeline Products by Stage of Development
  • Table 7: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Stage of Development
  • Table 8: A&B Professional di Barsali Brunella Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Diagnostic Kit - Parasitic Infection - Product Status
  • Table 10: Diagnostic Kit - Parasitic Infection - Product Description
  • Table 11: Akers Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: PIFA Hepatitis B - Product Status
  • Table 13: PIFA Hepatitis B - Product Description
  • Table 14: PIFA Hepatitis C - Product Status
  • Table 15: PIFA Hepatitis C - Product Description
  • Table 16: PIFA Syphilis Rapid Assay - Product Status
  • Table 17: PIFA Syphilis Rapid Assay - Product Description
  • Table 18: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: ASOslide Latex Slide Test - Product Status
  • Table 20: ASOslide Latex Slide Test - Product Description
  • Table 21: Aseptika Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Home-Use Sputum Test - Bacterial Lung Infection - Product Status
  • Table 23: Home-Use Sputum Test - Bacterial Lung Infection - Product Description
  • Table 24: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: AtomoRapid - Hepatitis C - Product Status
  • Table 26: AtomoRapid - Hepatitis C - Product Description
  • Table 27: AtomoRapid - Malaria - Product Status
  • Table 28: AtomoRapid - Malaria - Product Description
  • Table 29: Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Diagnostic Assay - Ebola Virus - Product Status
  • Table 31: Diagnostic Assay - Ebola Virus - Product Description
  • Table 32: BACTERIOSCAN LTD. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Antibiotic Susceptibility Testing (AST) - Model 3100Dx - Product Status
  • Table 34: Antibiotic Susceptibility Testing (AST) - Model 3100Dx - Product Description
  • Table 35: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Rapid Ebola Virus Triage Test - Product Status
  • Table 37: Rapid Ebola Virus Triage Test - Product Description
  • Table 38: BioFire Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: FilmArray Direct Sepsis Panel - Product Status
  • Table 40: FilmArray Direct Sepsis Panel - Product Description
  • Table 41: Biotech Consortium India Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Diagnostic Kit - Chlamydia Infection - Product Status
  • Table 43: Diagnostic Kit - Chlamydia Infection - Product Description
  • Table 44: Diagnostic Kit - Hepatitis A - Product Status
  • Table 45: Diagnostic Kit - Hepatitis A - Product Description
  • Table 46: Rotavirus Diagnostic Kit - Product Status
  • Table 47: Rotavirus Diagnostic Kit - Product Description
  • Table 48: Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Aware 2 HIV-1/2 - Product Status
  • Table 50: Aware 2 HIV-1/2 - Product Description
  • Table 51: Aware HIV-1/2 OMT - Product Status
  • Table 52: Aware HIV-1/2 OMT - Product Description
  • Table 53: Canon U.S.A., Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Diagnostic Test Panel - Lyme Disease - Product Status
  • Table 55: Diagnostic Test Panel - Lyme Disease - Product Description
  • Table 56: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: GeneXpert Omni - Flu/RSV - Product Status
  • Table 58: GeneXpert Omni - Flu/RSV - Product Description
  • Table 59: GeneXpert Omni - HPV - Product Status
  • Table 60: GeneXpert Omni - HPV - Product Description
  • Table 61: GeneXpert Omni - Xpress CT/NG - Product Status
  • Table 62: GeneXpert Omni - Xpress CT/NG - Product Description
  • Table 63: GeneXpert Omni - Xpress Flu/RSV - Product Status
  • Table 64: GeneXpert Omni - Xpress Flu/RSV - Product Description
  • Table 65: GeneXpert Omni - Xpress GBS Ultra - Product Status
  • Table 66: GeneXpert Omni - Xpress GBS Ultra - Product Description
  • Table 67: GeneXpert Omni - Xpress Group A Strep - Product Status
  • Table 68: GeneXpert Omni - Xpress Group A Strep - Product Description
  • Table 69: GeneXpert Omni - Xpress Pertussis - Product Status
  • Table 70: GeneXpert Omni - Xpress Pertussis - Product Description
  • Table 71: GeneXpert Omni - Xpress Vaginitis/Vaginosis - Product Status
  • Table 72: GeneXpert Omni - Xpress Vaginitis/Vaginosis - Product Description
  • Table 73: Xpert HCV Viral Load Assay - Product Status
  • Table 74: Xpert HCV Viral Load Assay - Product Description
  • Table 75: Xpert MTB/RIF Ultra - Product Status
  • Table 76: Xpert MTB/RIF Ultra - Product Description
  • Table 77: Xpert TV - Product Status
  • Table 78: Xpert TV - Product Description
  • Table 79: Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: HAT-PCR-Oligochromatographic Dipstick - Product Status
  • Table 81: HAT-PCR-Oligochromatographic Dipstick - Product Description
  • Table 82: Denka Seiken Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 83: QuickNavi - Ebola Rapid Antigen Detection Test Kit - Product Status
  • Table 84: QuickNavi - Ebola Rapid Antigen Detection Test Kit - Product Description
  • Table 85: Diagnostics for the Real World (Europe) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 86: SAMBA - HIV-1 RNA Assay - Product Status
  • Table 87: SAMBA - HIV-1 RNA Assay - Product Description
  • Table 88: DIESSE Diagnostica Senese S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 89: Rapid Urine Screening Test - Product Status
  • Table 90: Rapid Urine Screening Test - Product Description
  • Table 91: First Light Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 92: MultiPath UTI AST Assay - Product Status
  • Table 93: MultiPath UTI AST Assay - Product Description
  • Table 94: Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 95: 2nd Generation Rapid Diagnostic Test - Human African Trypanosomiasis - Product Status
  • Table 96: 2nd Generation Rapid Diagnostic Test - Human African Trypanosomiasis - Product Description
  • Table 97: Antibody Detection Test - Product Status
  • Table 98: Antibody Detection Test - Product Description
  • Table 99: Antigen Detection Test - Human African Trypanosomiasis - Product Status
  • Table 100: Antigen Detection Test - Human African Trypanosomiasis - Product Description
  • Table 101: BART - Malaria - Product Status
  • Table 102: BART - Malaria - Product Description
  • Table 103: Infection Detection Test - P. falciparum - Product Status
  • Table 104: Infection Detection Test - P. falciparum - Product Description
  • Table 105: P. vivax Serology Test - Product Status
  • Table 106: P. vivax Serology Test - Product Description
  • Table 107: Rapid Diagnostic Test - Neoptrin/CXCL13 - Product Status
  • Table 108: Rapid Diagnostic Test - Neoptrin/CXCL13 - Product Description
  • Table 109: Single Format IgM Quantification Test - Product Status
  • Table 110: Single Format IgM Quantification Test - Product Description
  • Table 111: Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 112: Diagnostic Assay - Ebola Virus - Product Status
  • Table 113: Diagnostic Assay - Ebola Virus - Product Description
  • Table 114: GeneFluidics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 115: BSI PID/AST CentriFluidic System - Product Status
  • Table 116: BSI PID/AST CentriFluidic System - Product Description
  • Table 117: Great Basin Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 118: Rapid Detection Test - Hypervirulent Strains Of Toxigenic C. difficile - Product Status
  • Table 119: Rapid Detection Test - Hypervirulent Strains Of Toxigenic C. difficile - Product Description
  • Table 120: Hema Diagnostic Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 121: Rapid 1-2-3 HEMA EXPRESS - Syphilis Assay - Product Status
  • Table 122: Rapid 1-2-3 HEMA EXPRESS - Syphilis Assay - Product Description
  • Table 123: Immunexpress Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 124: SeptiCyte PLUS - Product Status
  • Table 125: SeptiCyte PLUS - Product Description

List of Figures

  • Figure 1: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Stage of Development
  • Figure 2: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Segment
  • Figure 3: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Territory
  • Figure 4: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Regulatory Path
  • Figure 5: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Estimated Approval Date
Back to Top